Consonance Capital Management LP Atara Biotherapeutics, Inc. Transaction History

Consonance Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$12.89 - $16.58 $21.5 Million - $27.7 Million	-1,669,293 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$14.0 - $20.72 $26.1 Million - $38.6 Million	-1,863,445 Reduced 52.75%	1,669,293 $24 Million
Q4 2020 Feb 16, 2021	SELL	$12.67 - $26.23 $14.6 Million - $30.2 Million	-1,152,789 Reduced 24.6%	3,532,738 $69.3 Million
Q3 2020 Nov 16, 2020	SELL	$11.92 - $15.87 $6.59 Million - $8.77 Million	-552,691 Reduced 10.55%	4,685,527 $60.7 Million
Q2 2020 Aug 14, 2020	BUY	$7.53 - $14.93 $39.4 Million - $78.2 Million	5,238,218 New	5,238,218 $76.3 Million

3.06M

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $1.1B
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Consonance Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Consonance Capital Management LP with notifications on news.